Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 1/20 | 0.34 |
| ▸ | STAT1 | P42224 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3820256 | 0.98 | STAT3 (0.35) | STAT3STAT1 | |
| SCHEMBL25612 | 0.98 | STAT3 (0.35) | STAT3STAT1 | |
| SCHEMBL1684236 | 0.96 | STAT3 (0.34) | STAT3STAT1 | |
| Hydrochloric Acid SCHEMBL8403409 | 0.96 | STAT3 (0.34) | STAT3STAT1 | |
| SCHEMBL670040 | 0.96 | STAT3 (0.34) | STAT3STAT1 | |
| SCHEMBL6411978 | 0.96 | STAT3 (0.37) | STAT3STAT1 | |
| SCHEMBL98554 | 0.96 | STAT3 (0.34) | STAT3STAT1 | |
| SCHEMBL6418524 | 0.96 | STAT3 (0.37) | STAT3STAT1 | |
| SCHEMBL13584886 | 0.94 | STAT3 (0.33) | STAT3STAT1 | |
| Ethylene SCHEMBL18262006 | 0.93 | STAT3 (0.33) | STAT3STAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190307893-A1 | NANOVESICLES WITH PORPHYRIN-LIPID CONJUGATE CORE | UNIVERSITY HEALTH NETWORK (CA) | 2019-10-10 | — | — | US | disclosed |
| WO-2017156616-A1 | NANOVESICLES COMPRISING PORPHYRIN-LIPID CONJUGATES EXHIBITING ORDERED ASSEMBLY AND BATHOCHROMIC SHIFTS | UNIVERSITY HEALTH NETWORK (CA) | 2017-09-21 | — | — | WO | disclosed |
| US-9417245-B2 | Porphyrinic compounds for use in flow cytometry | NORTH CAROLINA STATE UNIVERSITY (US) | 2016-08-16 | — | — | US | disclosed |
| US-20150153350-A1 | PORPHYRINIC COMPOUNDS FOR USE IN FLOW CYTOMETRY | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-06-04 | — | — | US | disclosed |
| US-8980565-B2 | Porphyrinic compounds for use in flow cytometry | NORTH CAROLINA STATE UNIVERSITY (US) | 2015-03-17 | — | — | US | disclosed |
| US-8546088-B2 | Porphyrinic compounds for use in flow cytometry | NORTH CAROLINA STATE UNIVERSITY (US) | 2013-10-01 | — | — | US | disclosed |
| US-20120245508-A1 | SYNTHESIS OF CHLORINS AND PHORBINES WITH ENHANCED RED SPECTRAL FEATURES | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2012-09-27 | — | — | US | disclosed |
| US-20120244551-A1 | PORPHYRINIC COMPOUNDS FOR USE IN FLOW CYTOMETRY | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2012-09-27 | — | — | US | disclosed |
| US-8207329-B2 | Synthesis of chlorins and phorbines with enhanced red spectral features | NORTH CAROLINA STATE UNIVERSITY (US) | 2012-06-26 | — | — | US | disclosed |
| US-8187824-B2 | Porphyrinic compounds for use in flow cytometry | NORTH CAROLINA STATE UNIVERSITY (US) | 2012-05-29 | — | — | US | disclosed |
| US-20090075295-A1 | PORPHYRINIC COMPOUNDS FOR USE IN FLOW CYTOMETRY | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-03-19 | — | — | US | disclosed |
| WO-2007064841-A2 | PORPHYRINIC COMPOUNDS FOR USE IN FLOW CYTOMETRY | NORTH CAROLINA STATE UNIVERSITY (US) | 2007-06-07 | — | — | WO | disclosed |
| WO-2007064842-A2 | SYNTHESIS OF CHLORINS AND PHORBINES WITH ENHANCED RED SPECTRAL FEATURES | NORTH CAROLINA STATE UNIVERSITY (US) | 2007-06-07 | — | — | WO | disclosed |
| EP-1117666-B1 | PROCESS FOR THE PREPARATION OF CORROLES AND SEVERAL SUCH NEW COMPOUNDS, INCLUDING CHIRAL DERIVATIVES, AND THE USE THEREOF | TECHNION RES & DEV FOUNDATION (IL) | 2004-12-01 | — | — | EP | disclosed |
| EP-1469001-A1 | Corroles, including chiral derivatives and the use thereof | Technion Research & Development Foundation Limited (IL) | 2004-10-20 | — | — | EP | disclosed |
| US-6541628-B1 | Solvent-free condensation of an aldehyde with a pyrrole derivative to form corroles, salts or complexes | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) | 2003-04-01 | — | — | US | disclosed |
| CN-1085211-C | Synthetic metal-substituted bacteriochlorophyll derivs. and use thereof | YEDA RES & DEV (IL) | 2002-05-22 | — | — | CN | disclosed |
| EP-1117666-A2 | PROCESS FOR THE PREPARATION OF CORROLES AND SEVERAL SUCH NEW COMPOUNDS, INCLUDING CHIRAL DERIVATIVES, AND THE USE THEREOF | Technion Research & Development Foundation Limited (IL) | 2001-07-25 | — | — | EP | disclosed |
| WO-2000018771-A2 | PROCESS FOR THE PREPARATION OF CORROLES AND SEVERAL SUCH NEW COMPOUNDS, INCLUDING CHIRAL DERIVATIVES, AND THE USE THEREOF | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) | 2000-04-06 | — | — | WO | disclosed |
| CN-1207741-A | Synthetic metal substituted bacteriochlorophyll derivatives and their use | YEDA RES & DEV (IL) | 1999-02-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190307893-A1 | NANOVESICLES WITH PORPHYRIN-LIPID CONJUGATE CORE | PHOSPHO1, PCYT1A, CLTB | STAT3 4330/4885STAT1 4170/4885 |
| US-20120245508-A1 | SYNTHESIS OF CHLORINS AND PHORBINES WITH ENHANCED RED SPECTRAL FEATURES | CRY1, CRY2, QDPR | STAT3 3528/4885STAT1 3399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.